A guide to selecting high-performing antibodies for PLC-gamma-2 for use in Western Blot, immunoprecipitation and immunofluorescence
F1000Research · 2024
DOI: 10.12688/f1000research.146156.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift F1000Research, 2024. Verfasst von Vera Ruíz Moleón und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Neurosurgery, Structural Genomics Consortium, The Montreal Neurological Institute, McGill University, Montreal, Québec, H…. Hauptthemen laut MEDLINE: Phospholipase C gamma, Fluorescent Antibody Technique, Immunoprecipitation, Blotting, Western. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, Mitacs, Canadian Institutes of Health Research Foundation.
Abstract (Originalsprache)
Phosphatidylinositol-specific phospholipase C gamma 2 (PLC-gamma-2) is an enzyme that regulates the function of immune cells. PLC-gamma-2 has been implicated in neurodegenerative and autoimmune disorders, yet investigation of this protein has been limited by a lack of independently characterized antibodies. Here we have characterized eleven PLC-gamma-2 commercial antibodies for use in Western Blot, immunoprecipitation, and immunofluorescence using a standardized experimental protocol based on comparing read-outs in knockout cell lines and isogenic parental controls. These studies are part of a larger, collaborative initiative seeking to address antibody reproducibility issues by characterizing commercially available antibodies for human proteins and publishing the results openly as a resource for the scientific community. While use of antibodies and protocols vary between laboratories, we encourage readers to use this report as a guide to select the most appropriate antibodies for their specific needs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology and Neurosurgery, Structural Genomics Consortium, The Montreal Neurological Institute, McGill University, Montreal, Québec, H3A 2B4, Canada.
- Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, 46202, USA.
ORCID-Profile: Vera Ruíz Moleón, Charles Alende, Kathleen Southern, Carl Laflamme
Förderung
- NIA NIH HHS
- Mitacs
- Canadian Institutes of Health Research Foundation
- Genome Québec
- Genome Canada
- Ontario Genomics
- National Institute on Aging
- Indiana University School of Medicine Purdue University TaRget Enablement to Accelerate Therapy Development for Alzheimer’s Disease
Zitieren
APA
Ruíz Moleón, V., Fotouhi, M., Alende, C., Ayoubi, R., Bedford, L. M., Southern, K., Richardson, T. I., Laflamme, C., NeuroSGC/YCharOS/EDDU collaborative group, & ABIF consortium (2024). A guide to selecting high-performing antibodies for PLC-gamma-2 for use in Western Blot, immunoprecipitation and immunofluorescence. F1000Research. https://doi.org/10.12688/f1000research.146156.1
Vancouver
Ruíz Moleón V, Fotouhi M, Alende C, Ayoubi R, Bedford LM, Southern K, et al. A guide to selecting high-performing antibodies for PLC-gamma-2 for use in Western Blot, immunoprecipitation and immunofluorescence. F1000Research. 2024. doi:10.12688/f1000research.146156.1
BibTeX
@article{RuzMolen2024,
author = {Ruíz Moleón, Vera and Fotouhi, Maryam and Alende, Charles and Ayoubi, Riham and Bedford, Logan M and Southern, Kathleen and Richardson, Timothy I and Laflamme, Carl and NeuroSGC/YCharOS/EDDU collaborative group, NeuroSGC/YCharOS/EDDU collaborative group and ABIF consortium, ABIF consortium},
title = {A guide to selecting high-performing antibodies for PLC-gamma-2 for use in Western Blot, immunoprecipitation and immunofluorescence},
journal = {F1000Research},
year = {2024},
doi = {10.12688/f1000research.146156.1}
}
EUVIMED